Youth and Family Research Program, WPIC
Pittsburgh, Pennsylvania, 15213, United States
NCT Number: NCT03080259
The purpose of this study is to test clinical strategies that pediatric providers may use to prevent misuse and diversion of stimulants by their adolescent patients with ADHD.
Looking for future studies?
Notify Me13 year–18 year
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15213, United States
This study addresses the increase in diversion (selling, sharing, loaning, or trading) of prescription stimulant medications by adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD). In the absence of any standardized, empirically evaluated clinical strategies or interventions to prevent or decrease stimulant diversion, this project will test the effect of a brief provider-led intervention for stimulant diversion prevention among adolescents being prescribed stimulant medication in pediatric care. The investigators hypothesize that adolescents treated in pediatric practices randomized to the intervention will report decreased diversion, increased perceived risk of harm, and decreased intentions to divert compared to adolescents treated in pediatric practices randomized to treatment-as-usual. Secondary analyses will examine the effect of the intervention on additional contributing variables (e.g., patient, parent, and provider attitude and behavior change).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
provider training, patient/parent education and counseling, strategies for use by patients and parents, and treatment adjustments
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items indicating frequency (# of times) selling, sharing, trading, or loaning stimulant medication. Diversion frequency will increase less in the SDP group between baseline and follow-up assessments.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items measuring the degree to which participants believe that people risk harming themselves if they take ADHD medication without a prescription (responses range from "no risk" to "great risk"). Mean perceived harm will increase more after baseline for the SDP vs control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items measuring intention to share/sell/trade stimulant medication (responses range from "I definitely will" to "I definitely will not"). Intent to divert will increase less in the SDP vs control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items measuring teen's report of the frequency of provider utilization of stimulant diversion prevention techniques (responses range from "no" to "yes, more than once" in the last 6 months). Number of techniques endorsed as occurring at least once will increase. Number will increase after baseline more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Number of people and/or groups who know about the teen's ADHD medication prescription (sum total across items). Total number will decrease after baseline in the SDP vs control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Number of times approached to sell or share ADHD prescription medication. Number will decrease after baseline more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Increased likelihood (from "definitely not" to "definitely") of using diversion refusal skills. Score will increase after baseline more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Increased ease (from "very difficult" to "very easy") in perceived use of diversion refusal skills. Score will increase after baseline more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Increased frequency (from "never" to "almost always") of using diversion refusal skills. Frequency will increase more after baseline for the SDP vs control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items measuring knowledge of negative consequences of diversion; mean score will increase (responses for each consequence ranges from "very unlikely" to "likely"). Mean score will increase after baseline more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Assesses likelihood (response scale ranges from "I definitely would" to "I definitely would not") of diverting medication in specific situations. Mean response across items should increase toward "I definitely would not". Likelihood of diversion mean score will change after baseline toward "I definitely would not" more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items measuring approval of diversion by proximal social contacts; responses range from "strongly approve" to "strongly disapprove". Mean score will increase towards disapproval. Mean score will increase toward disapproval more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items measuring attempted parental monitoring of stimulant medication (e.g., During the last 6 months, how much did either of your parents try to know.......). Mean score of responses across items. Mean score will increase after baseline more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items measuring actual parental knowledge of teen's stimulant medication (e.g., During the last 6 months, how much did either of your parents really know.......). Mean score of responses across items. Mean score will increase after baseline more for the SDP than control group.
Time frame: baseline, 6 month follow-up, 12 month follow-up, 18 month follow-up
Items assessing frequency of parent-teen discussion about diversion-related behavior (e.g., "Within the last 6 months, my parents talked with me about keeping my ADHD diagnosis and ADHD medication private"). Responses range from "never" to "three or more times". Number of items endorsed as occurring at least once or more often will increase after baseline more for the SDP than control group.
University of Pittsburgh
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06626750
ADHD, Attention Deficit Disorder with Hyperactivity
Miami, Florida, United States
View Trial DetailsNCT04082234
ADHD, Attention Deficit Disorder with Hyperactivity
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05796427
ADHD, Attention Deficit Disorder with Hyperactivity
Chicago, Illinois, United States
View Trial DetailsNCT05119660
ADHD, Attention Deficit Disorder with Hyperactivity
East Providence, Rhode Island, United States
View Trial Details